Important matters

1. ZTE's net profit for 2023 increased 15.41% to RMB 9.326 billion, and plans to distribute 6.83 yuan to 10 shares

$ZTE (00763.HK)$According to the announcement, net profit attributable to common shareholders of listed companies in 2023 was 9.326 billion yuan (RMB, same below), up 15.41% year on year; basic earnings per share were 1.96 yuan, up 14.62% year on year. The board of directors recommended the company's 2023 profit distribution plan: 6.83 yuan in cash (tax included) will be distributed to all shareholders for every 10 shares based on the total share capital on the dividend dividend registration date.

2. Shunyu Optical Technology shipped about 104 million mobile phone lenses in February, an increase of 29.4% over the previous year

$SUNNY OPTICAL (02382.HK)$In February, mobile phone lens shipments were about 104 million pieces, up 1.1% from month to month, up 29.4% year on year; car lens shipments were 7.85 million pieces, down 35.2% from month to month, down 1.5% year on year; mobile phone camera module shipments were 52.067 million pieces, down 16.4% month on month, up 72.1% year on year.

3. Profit attributable to China Tobacco Hong Kong's annual equity holders increased 60% to HK$599 million, with final interest of HK$0.32

$CTIHK (06055.HK)$The results for the year ended 2023 were announced, with revenue of 11.836 billion yuan, an increase of 42.2% year-on-year; gross profit of 1,088 billion yuan, an increase of 35%. It recorded a net profit of 599 million yuan, an increase of 59.7%, and earnings of 87 cents per share. The final interest rate is 32 cents, and 20 cents for the same period last year.

4. Dongfeng Group Co., Ltd. issued a profit warning. The estimated annual net profit loss to mother will not exceed 4 billion yuan

Dongfeng Group Co., Ltd. announced that compared with net profit of 10.265 billion yuan for the 12 months ended 31 December 2022, the company expects a net profit loss of no more than 4 billion yuan for the 12 months ended 31 December 2023. According to the announcement, the main reason for this period's performance changes: 1. The market space for joint venture non-luxury brands has been drastically squeezed, and product prices have continued to decline. In 2023, the Group's joint venture sales volume fell by 16%, and profits fell sharply. 2. The Group's new energy business is still in the strategic investment period of 2023, and investment in R&D, brand and channel construction in the fields of new energy and intelligence continues to increase.

5. Dongyangguang Changjiang Pharmaceutical: Guangdong Dongyangguang Pharmaceutical is considering absorbing the merged company through a share exchange and resuming trading on the 11th

$HEC CJ PHARM (01558.HK)$According to the announcement, it was learned that the parent company Guangdong Dongyangguang Pharmaceutical is considering absorbing and merging the company through a share exchange, and will use the new H shares listed on the main board of the Stock Exchange in the form of an introduction as a cancellation price. Once the possible merger is completed, the company's listing status on the Stock Exchange will be cancelled. The possible merger and possible listing are still in the preliminary stages, and it is difficult to determine whether they will proceed. The company's shares have applied to resume trading on Monday (11th).

In addition, the direct shareholder Hong Kong Dongyangguang transferred 25.71% of its shares to Guangdong Dongyangyang Pharmaceutical, with a total consideration of $2,067 billion. Compared with the price of $9.14 per share, this is an 18.68% discount compared to the closing price before the suspension of trading.

Earnings Report

$CTIHK (06055.HK)$Profit attributable to equity holders increased by 60% to HK$599 million with final interest of HK$0.32

$GENSCRIPT BIO (01548.HK)$The loss attributable to shareholders of the release of annual results of US$954.77 million narrowed 57.91% year-on-year

$ZHOU HEI YA (01458.HK)$The total annual revenue is expected to increase 15.2%-17.4% year-on-year to 2.75 billion yuan

$CHOW SANG SANG (00116.HK)$Yingxi: It is estimated that owners of continuing operations should account for an annual profit of HK$1 billion to HK$1.1 billion

$DONGFENG GROUP (00489.HK)$A profit warning says that the net profit loss due to mother for the year is not more than 4 billion yuan

$XIABUXIABU (00520.HK)$Expected annual revenue of about 5.900 billion yuan, a year-on-year increase of about 25%

Important matters

$HEC CJ PHARM (01558.HK)$: Guangdong Dongyangguang Pharmaceutical is considering a share exchange to absorb the merged company and resume trading on the 11th

$HAOHAI BIOTEC (06826.HK)$A spray pump customization agreement was signed with Haohai Changxing

$CIMC VEHICLES (01839.HK)$May involve important planning matters. Trading of A-shares will be suspended from March 11

$JF WEALTH (09636.HK)$It is planned to acquire all shares of GF Insurance for 52 million yuan

Operational data

$SUNNY OPTICAL (02382.HK)$In February, the number of mobile phone lens shipments of about 104 million pieces increased 29.4% year-on-year

$Q TECH (01478.HK)$: Total camera module sales in February were 28.698 million units, up 7.3% year-on-year

$DONGFENG GROUP (00489.HK)$The cumulative car sales volume in January-February was 331,020 units, up about 26.2% year on year

$YUEXIU PROPERTY (00123.HK)$The cumulative contract sales amount from January to February was about 10.361 billion yuan

$CHINA JINMAO (00817.HK)$In February, it obtained a contract sales amount of 4.15 billion yuan

$SHIMAO GROUP (00813.HK)$: Total cumulative contract sales for the first two months was 4.35 billion yuan

$SEAZEN (01030.HK)$: Achieved contract sales amount of 4,020 billion yuan in February

$GEMDALE PPT (00535.HK)$: Total cumulative contract sales for January-February was 1.93 billion yuan

$ZHONGLIANG HLDG (02772.HK)$The February contract sales amount was about 1.73 billion yuan

$CHINA LONGYUAN (00916.HK)$Completed power generation capacity of 6.476 million megawatt-hours in February, up 9.56% year-on-year

Repurchase cancellation

$HSBC HOLDINGS (00005.HK)$On March 7, it cost HK$157 million to repurchase 2.6712 million shares

$STANCHART (02888.HK)$On March 7, it cost £21.428 million to buy back 3,2161,000 shares

$HAIER SMARTHOME (06690.HK)$On March 8, it spent 14.81 million yuan to buy back 600,000 A-shares

$AIA (01299.HK)$On March 8, it spent HK$14.023,600 to repurchase 230,800 shares

$SWIRE PACIFIC A (00019.HK)$On March 8, it cost HK$12.23 million to repurchase 193,000 shares

edit/new